Troy J Kemp

Jun 14, 2024 | onlinelibrary.wiley.com | Chau Huy Quang |Amy Chung |Troy J Kemp |Tupou Ratu

1 INTRODUCTION Human papillomavirus (HPV) vaccines are highly effective at preventing vaccine-type HPV infections and cervical cancer precursors.

May 9, 2024 | mdpi.com | Thomas Hickey |Troy J Kemp |Jordan B. Metz |Jimmie L. Bullock

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jun 29, 2023 | pubmed.ncbi.nlm.nih.gov | Kemp TJ |Pinto LA |Troy J Kemp |Isabel Park

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Jun 29, 2023 | journals.plos.org | Isabel Park |Troy J Kemp |Ligia A Pinto |PLOS Pathogens

Loading metrics Open Access Pearls AbstractThe HPV Serology Laboratory is leading a global partnership initiative aiming for standardization and harmonization of current serology assay platforms being used to assess immune responses to HPV vaccines. Serology standardization is particularly important given the increasing number of immunobridging trials relying on serology data for approval of new vaccine dosing schedules or vaccine formulations.